EUCTR2011-001673-70-SE进行中（未招募）不适用
EPO to protect renal function after cardiac surgery. EPRICS. A phase II double blind randomized controlled study. - EPRICS
Skånes Universitetssjukhus0 个研究点开始时间: 2011年6月10日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients planed for Coronary Artery Bypass Grafting (CABG).
- •Non-emergent CABG, eGFR-CyC< 60 ml/min and
- •written consent to participate
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •Uncontrolled hypertension, pregnancy or fertile woman (less than 50 years old), Epo treatment within 4 weeks, eGFR-CyC<15 or dialysis, known malignancy and Off-pump surgery
研究者
相似试验
已完成
2 期
Erythropoietin (EPO) to Protect Renal Function After Cardiac SurgeryKidney FailureRenal FailureNCT01423955Region Skane75
进行中（未招募）
1 期
MERCURI-2AKICTIS2024-515260-31-00Stichting Amsterdam UMC784
已完成
不适用
Protection against acute renal failure following cardiac surgeryISRCTN98672577Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)1,100
已完成
不适用
Perioperative renal protection in patients subject to cardio-pulmonary bypassCardiopulmonary bypassSurgeryISRCTN66959365Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)80
进行中（未招募）
1 期
Ciclosporin to Protect Renal function In Cardiac SurgeryRenal dysfunction after CABG surgeryEUCTR2014-004610-29-SESkanes University Hospital